Global Women's Health Market β Industry Trends and Forecast to 2031
Report ID: MS-1451 | Healthcare and Pharma | Last updated: Jul, 2024 | Formats*:
Women's health is a branch of medicine focusing on women's physical and emotional well-being. It includes unique concerns like menstrual cycles, birth control, and pregnancy. The World Health Organization defines health as complete well-being. However, the women's health market faces challenges due to limited health literacy and a shortage of skilled IT professionals in healthcare, restricting its growth.
Women's Health Report Highlights
Report Metrics | Details |
---|---|
Forecast period | 2019-2031 |
Base Year Of Estimation | 2023 |
Growth Rate | CAGR of 5.8% |
Key Market Players |
|
By Region |
|
Women's Health Market Trends
Growing financial investment in IT healthcare sector. Many key market players are actively investing in healthcare technology. Due to this rising investment means Women's Health Market is expecting better tools and services tailored to women's needs, like improved diagnostics, personalized treatments, and easy access to healthcare system through digital platforms. With advancements in technology women can benefit from more efficient and effective healthcare solutions that will cover various things regarding their well-being from reproductive health. Eventually the increasing funds in healthcare IT open the door to innovative solutions that can make healthcare for women more accessible, efficient, and of higher quality. Increasing connection between digitalization and the healthcare market Majority of key market players are evolving more and more technology into healthcare, and this is making a big impact on the Women's Health Market. The connection between digitalization and healthcare is growing, bringing better and personalized services for women. Through things like online consultations, health apps, and wearable devices, women can now manage their health more conveniently. This trend also showing improved communication between women and healthcare providers, promoting proactive and preventive healthcare measures. In short, the increasing link between technology and healthcare is making women's health services more advanced, personalized, and accessible.Women's Health Market Leading Players
The key players profiled in the report are AbbVie, Inc., Agile Therapeutics, Amgen, Inc., Apothecus Pharmaceutical Corp., Bayer AG, Blairex Laboratories, Inc., Ferring B.V., Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd.Growth Accelerators
Increasing cases of cancers and various disorders. More women facing cancers and health issues is driving the Women's Health Market. As these cases are increasing there is a higher demand for special healthcare services. This drives the need of development of better diagnostics, treatments, and preventive measures tailored for women. Pharmaceutical companies and healthcare providers are focusing more on creating solutions for the specific health challenges that women are facing. In simple words, the rise in women experiencing cancers and disorders is a big factor pushing advancements and growth in the Women's Health Market.Women's Health Market Segmentation analysis
The Global Women's Health is segmented by Application, and Region.. The Application segment categorizes the market based on its usage such as Contraceptives, Endometriosis & Uterine Fibroids, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome (PCOS), Postmenopausal Osteoporosis. Geographically, the market is assessed across key Regions like North America(United States.Canada.Mexico), South America(Brazil.Argentina.Chile.Rest of South America), Europe(Germany.France.Italy.United Kingdom.Benelux.Nordics.Rest of Europe), Asia Pacific(China.Japan.India.South Korea.Australia.Southeast Asia.Rest of Asia-Pacific), MEA(Middle East.Africa) and others, each presenting distinct growth opportunities and challenges influenced by the regions.
Challenges In Women's Health Market
Insufficient guidance regarding health challenging the market of Women's Health. Not having good health guidance is challenging the Women's Health Market. It means women are struggling to find good information about their health, leading to delayed decisions. This hampering the market because women might not make informed choices, especially about preventive care. It also causes healthcare disparities in places with less health education. To solve this key market players are continuously improving the health education and easy-to-understand information.Risks & Prospects in Women's Health Market
Opportunity to introduce more number of private hospitals and clinics in emerging economies. Opening more private hospitals and clinics in developing countries is a big chance among the key and local market players in the Women's Health Market. This means providing better healthcare system for women where it's needed most. Private facilities can offer specialized services and use advanced technology to fulfil women's health needs. It is also creating competition, encouraging better care and more innovation. Essentially, introducing more private healthcare places is a great opportunity to improve women's health services in these areas.- 1.1 Report description
- 1.2 Key market segments
- 1.3 Key benefits to the stakeholders
2: Executive Summary
- 2.1 Women's Health- Snapshot
- 2.2 Women's Health- Segment Snapshot
- 2.3 Women's Health- Competitive Landscape Snapshot
3: Market Overview
- 3.1 Market definition and scope
- 3.2 Key findings
- 3.2.1 Top impacting factors
- 3.2.2 Top investment pockets
- 3.3 Porterβs five forces analysis
- 3.3.1 Low bargaining power of suppliers
- 3.3.2 Low threat of new entrants
- 3.3.3 Low threat of substitutes
- 3.3.4 Low intensity of rivalry
- 3.3.5 Low bargaining power of buyers
- 3.4 Market dynamics
- 3.4.1 Drivers
- 3.4.2 Restraints
- 3.4.3 Opportunities
4: Women's Health Market by Application / by End Use
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Contraceptives
- 4.2.1 Key market trends, factors driving growth, and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Endometriosis & Uterine Fibroids
- 4.3.1 Key market trends, factors driving growth, and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4 Hormonal Infertility
- 4.4.1 Key market trends, factors driving growth, and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- 4.5 Menopause
- 4.5.1 Key market trends, factors driving growth, and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market share analysis by country
- 4.6 Polycystic Ovary Syndrome (PCOS)
- 4.6.1 Key market trends, factors driving growth, and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market share analysis by country
- 4.7 Postmenopausal Osteoporosis
- 4.7.1 Key market trends, factors driving growth, and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market share analysis by country
5: Women's Health Market by Drug Outlook
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 ACTONEL
- 5.2.1 Key market trends, factors driving growth, and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 FORTEO
- 5.3.1 Key market trends, factors driving growth, and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- 5.4 Minastrin 24 Fe
- 5.4.1 Key market trends, factors driving growth, and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
- 5.5 Mirena
- 5.5.1 Key market trends, factors driving growth, and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country
- 5.6 NuvaRing
- 5.6.1 Key market trends, factors driving growth, and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market share analysis by country
- 5.7 ORTHO TRI-CY LO
- 5.7.1 Key market trends, factors driving growth, and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market share analysis by country
- 5.8 Others
- 5.8.1 Key market trends, factors driving growth, and opportunities
- 5.8.2 Market size and forecast, by region
- 5.8.3 Market share analysis by country
- 5.9 Premarin
- 5.9.1 Key market trends, factors driving growth, and opportunities
- 5.9.2 Market size and forecast, by region
- 5.9.3 Market share analysis by country
- 5.10 Prolia
- 5.10.1 Key market trends, factors driving growth, and opportunities
- 5.10.2 Market size and forecast, by region
- 5.10.3 Market share analysis by country
- 5.11 Reclast/Aclasta
- 5.11.1 Key market trends, factors driving growth, and opportunities
- 5.11.2 Market size and forecast, by region
- 5.11.3 Market share analysis by country
- 5.12 XGEVA
- 5.12.1 Key market trends, factors driving growth, and opportunities
- 5.12.2 Market size and forecast, by region
- 5.12.3 Market share analysis by country
- 5.13 YAZ
- 5.13.1 Key market trends, factors driving growth, and opportunities
- 5.13.2 Market size and forecast, by region
- 5.13.3 Market share analysis by country
- 5.14 Yasmin
- 5.14.1 Key market trends, factors driving growth, and opportunities
- 5.14.2 Market size and forecast, by region
- 5.14.3 Market share analysis by country
- 5.15 Yasminelle
- 5.15.1 Key market trends, factors driving growth, and opportunities
- 5.15.2 Market size and forecast, by region
- 5.15.3 Market share analysis by country
- 5.16 Zometa
- 5.16.1 Key market trends, factors driving growth, and opportunities
- 5.16.2 Market size and forecast, by region
- 5.16.3 Market share analysis by country
6: Women's Health Market by Age Outlook
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 50 years and above
- 6.2.1 Key market trends, factors driving growth, and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3 Others
- 6.3.1 Key market trends, factors driving growth, and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
7: Women's Health Market by Region
- 7.1 Overview
- 7.1.1 Market size and forecast By Region
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 Market size and forecast, by Type
- 7.2.3 Market size and forecast, by Application
- 7.2.4 Market size and forecast, by country
- 7.2.4.1 United States
- 7.2.4.1.1 Key market trends, factors driving growth, and opportunities
- 7.2.4.1.2 Market size and forecast, by Type
- 7.2.4.1.3 Market size and forecast, by Application
- 7.2.4.2 Canada
- 7.2.4.2.1 Key market trends, factors driving growth, and opportunities
- 7.2.4.2.2 Market size and forecast, by Type
- 7.2.4.2.3 Market size and forecast, by Application
- 7.2.4.3 Mexico
- 7.2.4.3.1 Key market trends, factors driving growth, and opportunities
- 7.2.4.3.2 Market size and forecast, by Type
- 7.2.4.3.3 Market size and forecast, by Application
- 7.2.4.1 United States
- 7.3 South America
- 7.3.1 Key trends and opportunities
- 7.3.2 Market size and forecast, by Type
- 7.3.3 Market size and forecast, by Application
- 7.3.4 Market size and forecast, by country
- 7.3.4.1 Brazil
- 7.3.4.1.1 Key market trends, factors driving growth, and opportunities
- 7.3.4.1.2 Market size and forecast, by Type
- 7.3.4.1.3 Market size and forecast, by Application
- 7.3.4.2 Argentina
- 7.3.4.2.1 Key market trends, factors driving growth, and opportunities
- 7.3.4.2.2 Market size and forecast, by Type
- 7.3.4.2.3 Market size and forecast, by Application
- 7.3.4.3 Chile
- 7.3.4.3.1 Key market trends, factors driving growth, and opportunities
- 7.3.4.3.2 Market size and forecast, by Type
- 7.3.4.3.3 Market size and forecast, by Application
- 7.3.4.4 Rest of South America
- 7.3.4.4.1 Key market trends, factors driving growth, and opportunities
- 7.3.4.4.2 Market size and forecast, by Type
- 7.3.4.4.3 Market size and forecast, by Application
- 7.3.4.1 Brazil
- 7.4 Europe
- 7.4.1 Key trends and opportunities
- 7.4.2 Market size and forecast, by Type
- 7.4.3 Market size and forecast, by Application
- 7.4.4 Market size and forecast, by country
- 7.4.4.1 Germany
- 7.4.4.1.1 Key market trends, factors driving growth, and opportunities
- 7.4.4.1.2 Market size and forecast, by Type
- 7.4.4.1.3 Market size and forecast, by Application
- 7.4.4.2 France
- 7.4.4.2.1 Key market trends, factors driving growth, and opportunities
- 7.4.4.2.2 Market size and forecast, by Type
- 7.4.4.2.3 Market size and forecast, by Application
- 7.4.4.3 Italy
- 7.4.4.3.1 Key market trends, factors driving growth, and opportunities
- 7.4.4.3.2 Market size and forecast, by Type
- 7.4.4.3.3 Market size and forecast, by Application
- 7.4.4.4 United Kingdom
- 7.4.4.4.1 Key market trends, factors driving growth, and opportunities
- 7.4.4.4.2 Market size and forecast, by Type
- 7.4.4.4.3 Market size and forecast, by Application
- 7.4.4.5 Benelux
- 7.4.4.5.1 Key market trends, factors driving growth, and opportunities
- 7.4.4.5.2 Market size and forecast, by Type
- 7.4.4.5.3 Market size and forecast, by Application
- 7.4.4.6 Nordics
- 7.4.4.6.1 Key market trends, factors driving growth, and opportunities
- 7.4.4.6.2 Market size and forecast, by Type
- 7.4.4.6.3 Market size and forecast, by Application
- 7.4.4.7 Rest of Europe
- 7.4.4.7.1 Key market trends, factors driving growth, and opportunities
- 7.4.4.7.2 Market size and forecast, by Type
- 7.4.4.7.3 Market size and forecast, by Application
- 7.4.4.1 Germany
- 7.5 Asia Pacific
- 7.5.1 Key trends and opportunities
- 7.5.2 Market size and forecast, by Type
- 7.5.3 Market size and forecast, by Application
- 7.5.4 Market size and forecast, by country
- 7.5.4.1 China
- 7.5.4.1.1 Key market trends, factors driving growth, and opportunities
- 7.5.4.1.2 Market size and forecast, by Type
- 7.5.4.1.3 Market size and forecast, by Application
- 7.5.4.2 Japan
- 7.5.4.2.1 Key market trends, factors driving growth, and opportunities
- 7.5.4.2.2 Market size and forecast, by Type
- 7.5.4.2.3 Market size and forecast, by Application
- 7.5.4.3 India
- 7.5.4.3.1 Key market trends, factors driving growth, and opportunities
- 7.5.4.3.2 Market size and forecast, by Type
- 7.5.4.3.3 Market size and forecast, by Application
- 7.5.4.4 South Korea
- 7.5.4.4.1 Key market trends, factors driving growth, and opportunities
- 7.5.4.4.2 Market size and forecast, by Type
- 7.5.4.4.3 Market size and forecast, by Application
- 7.5.4.5 Australia
- 7.5.4.5.1 Key market trends, factors driving growth, and opportunities
- 7.5.4.5.2 Market size and forecast, by Type
- 7.5.4.5.3 Market size and forecast, by Application
- 7.5.4.6 Southeast Asia
- 7.5.4.6.1 Key market trends, factors driving growth, and opportunities
- 7.5.4.6.2 Market size and forecast, by Type
- 7.5.4.6.3 Market size and forecast, by Application
- 7.5.4.7 Rest of Asia-Pacific
- 7.5.4.7.1 Key market trends, factors driving growth, and opportunities
- 7.5.4.7.2 Market size and forecast, by Type
- 7.5.4.7.3 Market size and forecast, by Application
- 7.5.4.1 China
- 7.6 MEA
- 7.6.1 Key trends and opportunities
- 7.6.2 Market size and forecast, by Type
- 7.6.3 Market size and forecast, by Application
- 7.6.4 Market size and forecast, by country
- 7.6.4.1 Middle East
- 7.6.4.1.1 Key market trends, factors driving growth, and opportunities
- 7.6.4.1.2 Market size and forecast, by Type
- 7.6.4.1.3 Market size and forecast, by Application
- 7.6.4.2 Africa
- 7.6.4.2.1 Key market trends, factors driving growth, and opportunities
- 7.6.4.2.2 Market size and forecast, by Type
- 7.6.4.2.3 Market size and forecast, by Application
- 7.6.4.1 Middle East
- 8.1 Overview
- 8.2 Key Winning Strategies
- 8.3 Top 10 Players: Product Mapping
- 8.4 Competitive Analysis Dashboard
- 8.5 Market Competition Heatmap
- 8.6 Leading Player Positions, 2022
9: Company Profiles
- 9.1 AbbVie
- 9.1.1 Company Overview
- 9.1.2 Key Executives
- 9.1.3 Company snapshot
- 9.1.4 Active Business Divisions
- 9.1.5 Product portfolio
- 9.1.6 Business performance
- 9.1.7 Major Strategic Initiatives and Developments
- 9.2 Inc.
- 9.2.1 Company Overview
- 9.2.2 Key Executives
- 9.2.3 Company snapshot
- 9.2.4 Active Business Divisions
- 9.2.5 Product portfolio
- 9.2.6 Business performance
- 9.2.7 Major Strategic Initiatives and Developments
- 9.3 Agile Therapeutics
- 9.3.1 Company Overview
- 9.3.2 Key Executives
- 9.3.3 Company snapshot
- 9.3.4 Active Business Divisions
- 9.3.5 Product portfolio
- 9.3.6 Business performance
- 9.3.7 Major Strategic Initiatives and Developments
- 9.4 Amgen
- 9.4.1 Company Overview
- 9.4.2 Key Executives
- 9.4.3 Company snapshot
- 9.4.4 Active Business Divisions
- 9.4.5 Product portfolio
- 9.4.6 Business performance
- 9.4.7 Major Strategic Initiatives and Developments
- 9.5 Inc.
- 9.5.1 Company Overview
- 9.5.2 Key Executives
- 9.5.3 Company snapshot
- 9.5.4 Active Business Divisions
- 9.5.5 Product portfolio
- 9.5.6 Business performance
- 9.5.7 Major Strategic Initiatives and Developments
- 9.6 Apothecus Pharmaceutical Corp.
- 9.6.1 Company Overview
- 9.6.2 Key Executives
- 9.6.3 Company snapshot
- 9.6.4 Active Business Divisions
- 9.6.5 Product portfolio
- 9.6.6 Business performance
- 9.6.7 Major Strategic Initiatives and Developments
- 9.7 Bayer AG
- 9.7.1 Company Overview
- 9.7.2 Key Executives
- 9.7.3 Company snapshot
- 9.7.4 Active Business Divisions
- 9.7.5 Product portfolio
- 9.7.6 Business performance
- 9.7.7 Major Strategic Initiatives and Developments
- 9.8 Blairex Laboratories
- 9.8.1 Company Overview
- 9.8.2 Key Executives
- 9.8.3 Company snapshot
- 9.8.4 Active Business Divisions
- 9.8.5 Product portfolio
- 9.8.6 Business performance
- 9.8.7 Major Strategic Initiatives and Developments
- 9.9 Inc.
- 9.9.1 Company Overview
- 9.9.2 Key Executives
- 9.9.3 Company snapshot
- 9.9.4 Active Business Divisions
- 9.9.5 Product portfolio
- 9.9.6 Business performance
- 9.9.7 Major Strategic Initiatives and Developments
- 9.10 Ferring B.V.
- 9.10.1 Company Overview
- 9.10.2 Key Executives
- 9.10.3 Company snapshot
- 9.10.4 Active Business Divisions
- 9.10.5 Product portfolio
- 9.10.6 Business performance
- 9.10.7 Major Strategic Initiatives and Developments
- 9.11 Merck & Co.
- 9.11.1 Company Overview
- 9.11.2 Key Executives
- 9.11.3 Company snapshot
- 9.11.4 Active Business Divisions
- 9.11.5 Product portfolio
- 9.11.6 Business performance
- 9.11.7 Major Strategic Initiatives and Developments
- 9.12 Inc.
- 9.12.1 Company Overview
- 9.12.2 Key Executives
- 9.12.3 Company snapshot
- 9.12.4 Active Business Divisions
- 9.12.5 Product portfolio
- 9.12.6 Business performance
- 9.12.7 Major Strategic Initiatives and Developments
- 9.13 Pfizer
- 9.13.1 Company Overview
- 9.13.2 Key Executives
- 9.13.3 Company snapshot
- 9.13.4 Active Business Divisions
- 9.13.5 Product portfolio
- 9.13.6 Business performance
- 9.13.7 Major Strategic Initiatives and Developments
- 9.14 Inc.
- 9.14.1 Company Overview
- 9.14.2 Key Executives
- 9.14.3 Company snapshot
- 9.14.4 Active Business Divisions
- 9.14.5 Product portfolio
- 9.14.6 Business performance
- 9.14.7 Major Strategic Initiatives and Developments
- 9.15 Teva Pharmaceutical Industries Ltd.
- 9.15.1 Company Overview
- 9.15.2 Key Executives
- 9.15.3 Company snapshot
- 9.15.4 Active Business Divisions
- 9.15.5 Product portfolio
- 9.15.6 Business performance
- 9.15.7 Major Strategic Initiatives and Developments
10: Analyst Perspective and Conclusion
- 10.1 Concluding Recommendations and Analysis
- 10.2 Strategies for Market Potential
Scope of Report
Aspects | Details |
---|---|
By Application |
|
By Drug Outlook |
|
By Age Outlook |
|
Report Licenses
Frequently Asked Questions (FAQ):
How do regulatory policies impact the Women's Health Market?
+
-
What major players in Women's Health Market?
+
-
What applications are categorized in the Women's Health market study?
+
-
Which product types are examined in the Women's Health Market Study?
+
-
Which regions are expected to show the fastest growth in the Women's Health market?
+
-
What are the major growth drivers in the Women's Health market?
+
-
Is the study period of the Women's Health flexible or fixed?
+
-
How do economic factors influence the Women's Health market?
+
-
How does the supply chain affect the Women's Health Market?
+
-
Which players are included in the research coverage of the Women's Health Market Study?
+
-